|
RAD51C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04560000002696E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.15019999999711E-05 |
| Normal-vs-Stage2 |
1.612090E-04 |
| Normal-vs-Stage3 |
1.44930000223198E-08 |
| Normal-vs-Stage4 |
6.41719999999735E-05 |
| Stage1-vs-Stage2 |
3.387200E-01 |
| Stage1-vs-Stage3 |
8.019100E-03 |
| Stage1-vs-Stage4 |
2.810800E-01 |
| Stage2-vs-Stage3 |
3.353400E-01 |
| Stage2-vs-Stage4 |
8.678200E-01 |
| Stage3-vs-Stage4 |
4.515200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.31409999957344E-07 |
| Normal-vs-AfricanAmerican |
1.262260E-03 |
| Normal-vs-Asian |
1.306390E-01 |
| Caucasian-vs-AfricanAmerican |
3.789600E-01 |
| Caucasian-vs-Asian |
7.770800E-01 |
| AfricanAmerican-vs-Asian |
9.486200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.90000000177548E-08 |
| Normal-vs-Female |
1.70013999999385E-05 |
| Male-vs-Female |
4.590000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.624400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.21149999998682E-06 |
| Normal-vs-Age(61-80Yrs) |
9.16109999971049E-07 |
| Normal-vs-Age(81-100Yrs) |
8.393900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.719200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.525400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.688400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.373200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.416200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.731800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.467800E-02 |
| Normal-vs-Grade 2 |
8.43070000000612E-05 |
| Normal-vs-Grade 3 |
1.48679999978363E-07 |
| Normal-vs-Grade 4 |
1.76206999999984E-05 |
| Grade 1-vs-Grade 2 |
5.218200E-01 |
| Grade 1-vs-Grade 3 |
1.361820E-01 |
| Grade 1-vs-Grade 4 |
8.222400E-02 |
| Grade 2-vs-Grade 3 |
1.426060E-02 |
| Grade 2-vs-Grade 4 |
1.003590E-01 |
| Grade 3-vs-Grade 4 |
8.720800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.12529999990652E-07 |
| Normal-vs-ccB subtype |
9.71969999999933E-05 |
| ccA subtype-vs-ccB subtype |
2.433400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.92419999950944E-07 |
| Normal-vs-N1 |
2.217700E-02 |
| N0-vs-N1 |
8.818600E-01 |
|
|
